Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanjie Liu

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Aging|July 24, 2020
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastomaGuanzhang Li, You Zhai, Hanjie Liu, et al.
International Journal of Biological Sciences|May 29, 2026
Fangchinoline Activates cGAS-STING to Promote Antitumor Immunity without Pathological InflammationYang Zhao, Xingyu Chen, Yunfei Xie, et al.
Cardiovascular Toxicology|June 25, 2025
Empagliflozin Promotes Revascularization in Diabetic Mice Hindlimb Ischemia by Improving Vascular Endothelial Cell FunctionHanjie Liu, Yingfan Li, Xiaoqi Zhou, et al.
JCI Insight|February 10, 2025
The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastomaJinqiu Liu, Yuxuan Deng, Zhuonan Pu, et al.
CNS Neuroscience & Therapeutics|October 28, 2021
Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro studyHao Wu, Lin Yang, Hanjie Liu, et al.
Nature Communications|August 6, 2020
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomasBarbara Oldrini, Nuria Vaquero-Siguero, Quanhua Mu, et al.
Redox Biology|September 5, 2022
Nrf2 transcriptional upregulation of IDH2 to tune mitochondrial dynamics and rescue angiogenic function of diabetic EPCsXiaozhen Dai, Kai Wang, Jiawei Fan, et al.
Science Translational Medicine|October 4, 2023
Identifying predictors of glioma evolution from longitudinal sequencingQuanhua Mu, Ruichao Chai, Bo Pang, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Aging|July 24, 2020
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastomaGuanzhang Li, You Zhai, Hanjie Liu, et al.
International Journal of Biological Sciences|May 29, 2026
Fangchinoline Activates cGAS-STING to Promote Antitumor Immunity without Pathological InflammationYang Zhao, Xingyu Chen, Yunfei Xie, et al.
Cardiovascular Toxicology|June 25, 2025
Empagliflozin Promotes Revascularization in Diabetic Mice Hindlimb Ischemia by Improving Vascular Endothelial Cell FunctionHanjie Liu, Yingfan Li, Xiaoqi Zhou, et al.
JCI Insight|February 10, 2025
The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastomaJinqiu Liu, Yuxuan Deng, Zhuonan Pu, et al.
CNS Neuroscience & Therapeutics|October 28, 2021
Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro studyHao Wu, Lin Yang, Hanjie Liu, et al.
Nature Communications|August 6, 2020
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomasBarbara Oldrini, Nuria Vaquero-Siguero, Quanhua Mu, et al.
Redox Biology|September 5, 2022
Nrf2 transcriptional upregulation of IDH2 to tune mitochondrial dynamics and rescue angiogenic function of diabetic EPCsXiaozhen Dai, Kai Wang, Jiawei Fan, et al.
Science Translational Medicine|October 4, 2023
Identifying predictors of glioma evolution from longitudinal sequencingQuanhua Mu, Ruichao Chai, Bo Pang, et al.
Pageof 6